Skip to main content

People in the News: David Flannery, Tim Cooley, Kevin Krenzke

Premium

The American College of Medical Genetics and Genomics has appointed David Flannery to medical director. Flannery is board-certified in both clinical genetics and pediatrics, and he joins ACMG from the Medical College of Georgia where he served in a variety of clinical, academic, and medical staff leadership positions since 1984, including professor of pediatrics and chief of the genetics division. He is a founding fellow of ACMG and he is currently the ACMG representative to the American Medical Association's CPT Advisory Committee. He has also served as a member of the Southeast Regional Newborn Screening & Genetics Collaboratives.


MolecularHealth has added two new members to its US executive team: Tim Cooley and Kevin Krenzke.

Cooley will be senior VP of IT at MolecularHealth. He previously spent 15 years at Eli Lilly, where he held various positions, including director of IT. Krenzke will be senior VP of finance at MolecularHealth. He joins the firm after holding leadership roles at McKesson Specialty Health and US Oncology.

The new additions to the MolecularHealth team come as the company is readying to launch in the first quarter its TreatmentMap next-gen sequencing-based tests to guide cancer treatment.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.